Substituted biaryl piperazinyl-pyridine analogues
US7662830B2 · kind B2 · utility
1Cited by
9References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2005 |
| Grant date | Feb 16, 2010 |
| Priority date | — |
| Expiry date | Jan 8, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted biaryl piperazinyl-pyridine analogues are provided, of the Formula:wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptors activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.